Cataract Formation and Other Complications of Intravitreal Triamcinolone for Macular Edema
- 1 April 2006
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 141 (4), 629-629.e10
- https://doi.org/10.1016/j.ajo.2005.11.050
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusionAlbrecht von Graefes Archiv für Ophthalmologie, 2002
- Intravitreal triamcinolone for refractory diabetic macular edemaOphthalmology, 2002
- Intravitreal triamcinolone acetonide for macular oedema due to central retinal vein occlusionBritish Journal of Ophthalmology, 2002
- Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edemaAmerican Journal of Ophthalmology, 2001
- Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography studyOphthalmology, 2001
- Safety and efficacy of intravitreal triamcinolone for cystoid macular oedema in uveitisClinical & Experimental Ophthalmology, 2001
- INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATIONRetina, 2000
- Experimental and Clinical Observations of the Intraocular Toxicity of Commercial Corticosteroid PreparationsAmerican Journal of Ophthalmology, 1986
- The Lack of Toxicity of Intravitreally Administered Triamcinolone AcetonideAmerican Journal of Ophthalmology, 1981
- Inhibition of Intraocular Proliferations with Intravitreal CorticosteriodsAmerican Journal of Ophthalmology, 1980